ROSEN, A RESPECTED LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses to Secure Counsel Before Important February 28 Deadline in Securities Class Action – INSD, MZKR – QNT Press Release

[ad_1]

NEW YORK, Feb. 19, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC:INSDMZKR)) between December 8, 2020 and November 24, 2021, inclusive (the “Class Period”), of the important February 28, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Instadose securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Instadose class action, go to https://rosenlegal.com/submit-form/?case_id=2750 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 28, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often firms, issuing notices do …

Full story available on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center